Renal prostaglandins E2 and I2. Aspects of metabolism, and relationship to renal hemodynamics and renin release mechanisms.

Journal of the Oslo city hospitals Pub Date : 1989-11-01
J F Bugge
{"title":"Renal prostaglandins E2 and I2. Aspects of metabolism, and relationship to renal hemodynamics and renin release mechanisms.","authors":"J F Bugge","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Similar distributions of prostaglandins in urine and renal venous blood both during prostaglandin infusion and stimulated synthesis indicated a vascular origin for both urinary and renal venous PGE2 and PGI2. Various stimulation procedures demonstrated that the renal vasculature releases PGE2 and PGI2 in a fixed proportion. Renal degradation of circulating prostaglandins was not influenced by ureteral occlusion and seems to be mainly confined to the blood vessels. The vascular capacity for both synthesis and degradation was much greater for PGE2 than for PGI2. Urinary PGE2 was shown to be of renal origin, but constituted a small and variable fraction of renally produced PGE2, making it a poor estimate of renal PGE2 synthesis. Urinary 6-keto-PGF1 alpha may originate from renal PGI2 production or from circulating 6-keto-PGF1 alpha which readily appears in the urine. Equimolar infusions of PGE2 and PGI2 demonstrated that PGI2 was a more potent stimulator of renin release than PGE2, but the difference seemed to be mainly due to differences in degradation and not to differences in intrinsic potency. Prostaglandins stimulated renin release only when the intrarenal mechanisms for renin release were activated and not at control blood pressure and free urine flow. beta-adrenoceptor agonists stimulated renin release independently of activation of the macula densa, but required activation of the hemodynamic mechanism. Ethacrynic acid activated both the hemodynamic and the macula densa mechanism, but had no direct stimulatory effect on renin release. PGE2 and PGI2 were released during autoregulatory vasodilation, but neither PGE2 nor PGI2 participated in the autoregulatory mechanism. Autoregulatory and prostaglandin mediated vasodilation seems to be independent. Descending autoregulatory vasodilation was demonstrated during successive reductions in RAP, but a more simultaneous dilation of all preglomerular vessels was indicated during successive elevations of ureteral pressure. This difference may be due to participation of TGF together with the myogenic mechanism in autoregulation of RBF. Participation of TGF may also explain why prostaglandin and renin release dissociate during successive reductions in RAP, but increase in parallel during successive elevations of ureteral pressure. It also explains why maximal renin release induced both by the hemodynamic and the macula densa mechanism coincides with the breaking point of the RBF autoregulatory curve, and why loop diuretics induce complete autoregulatory vasodilation at control blood pressure.</p>","PeriodicalId":76055,"journal":{"name":"Journal of the Oslo city hospitals","volume":"39 11-12","pages":"123-36"},"PeriodicalIF":0.0000,"publicationDate":"1989-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Oslo city hospitals","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Similar distributions of prostaglandins in urine and renal venous blood both during prostaglandin infusion and stimulated synthesis indicated a vascular origin for both urinary and renal venous PGE2 and PGI2. Various stimulation procedures demonstrated that the renal vasculature releases PGE2 and PGI2 in a fixed proportion. Renal degradation of circulating prostaglandins was not influenced by ureteral occlusion and seems to be mainly confined to the blood vessels. The vascular capacity for both synthesis and degradation was much greater for PGE2 than for PGI2. Urinary PGE2 was shown to be of renal origin, but constituted a small and variable fraction of renally produced PGE2, making it a poor estimate of renal PGE2 synthesis. Urinary 6-keto-PGF1 alpha may originate from renal PGI2 production or from circulating 6-keto-PGF1 alpha which readily appears in the urine. Equimolar infusions of PGE2 and PGI2 demonstrated that PGI2 was a more potent stimulator of renin release than PGE2, but the difference seemed to be mainly due to differences in degradation and not to differences in intrinsic potency. Prostaglandins stimulated renin release only when the intrarenal mechanisms for renin release were activated and not at control blood pressure and free urine flow. beta-adrenoceptor agonists stimulated renin release independently of activation of the macula densa, but required activation of the hemodynamic mechanism. Ethacrynic acid activated both the hemodynamic and the macula densa mechanism, but had no direct stimulatory effect on renin release. PGE2 and PGI2 were released during autoregulatory vasodilation, but neither PGE2 nor PGI2 participated in the autoregulatory mechanism. Autoregulatory and prostaglandin mediated vasodilation seems to be independent. Descending autoregulatory vasodilation was demonstrated during successive reductions in RAP, but a more simultaneous dilation of all preglomerular vessels was indicated during successive elevations of ureteral pressure. This difference may be due to participation of TGF together with the myogenic mechanism in autoregulation of RBF. Participation of TGF may also explain why prostaglandin and renin release dissociate during successive reductions in RAP, but increase in parallel during successive elevations of ureteral pressure. It also explains why maximal renin release induced both by the hemodynamic and the macula densa mechanism coincides with the breaking point of the RBF autoregulatory curve, and why loop diuretics induce complete autoregulatory vasodilation at control blood pressure.

肾前列腺素E2和I2。代谢方面,以及与肾血流动力学和肾素释放机制的关系。
在前列腺素输注和刺激合成过程中,尿和肾静脉血中前列腺素的分布相似,表明尿和肾静脉中PGE2和PGI2都有血管来源。各种刺激方法表明,肾血管以固定比例释放PGE2和PGI2。循环前列腺素的肾脏降解不受输尿管阻塞的影响,似乎主要局限于血管。PGE2的血管合成和降解能力都比PGI2大得多。尿PGE2被证明是肾源性的,但在肾脏生成的PGE2中只占很小的可变部分,因此不能很好地估计肾脏PGE2的合成。尿6-酮- pgf1 α可能源于肾脏PGI2的产生或来自循环中的6-酮- pgf1 α,它很容易出现在尿液中。等摩尔输注PGE2和PGI2表明,PGI2比PGE2更有效地刺激肾素释放,但这种差异似乎主要是由于降解的差异,而不是内在效力的差异。前列腺素只有在肾内肾素释放机制被激活时才刺激肾素释放,而不是在控制血压和自由尿流的情况下。肾上腺素受体激动剂刺激肾素释放独立于激活黄斑致密,但需要激活血流动力学机制。乙酸对肾素释放无直接刺激作用,但对血流动力学和黄斑致密机制均有激活作用。PGE2和PGI2在自调节性血管舒张过程中释放,但PGE2和PGI2均不参与自调节机制。自我调节和前列腺素介导的血管舒张似乎是独立的。在RAP的连续降低过程中表现为下行自调节性血管舒张,但在输尿管压力的连续升高过程中表现为所有肾小球前血管的同步扩张。这种差异可能是由于TGF和成肌机制共同参与了RBF的自动调节。TGF的参与也可以解释为什么在RAP的连续降低过程中前列腺素和肾素释放分离,但在输尿管压力的连续升高过程中却平行增加。这也解释了为什么血流动力学和黄斑致密机制诱导的最大肾素释放与RBF自调节曲线的断点一致,以及为什么利尿剂在控制血压的情况下诱导完全的自调节血管舒张。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信